ランダム化制御試験における乾燥眼の徴候および症状に対するプラセボまたは媒介体の効果:体系的なレビューとメタ解析
Alan Huang1, Annie Zhang2, Daniel Lee2
1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Survey of ophthalmology
|August 29, 2025
まとめ
乾燥眼疾患 (DED) 試験におけるプラセボ効果は,症状と徴候の両方において有意である. 女性の性別と初期症状の悪化は,プラセボに対するDED症状の反応に影響します.
科学分野:
- 眼科について
- 臨床試験
- 証拠 に 基づく 医学
背景:
- 乾燥眼症 (DED) は一般的な眼疾患である.
- DEDの臨床試験では,プラセボまたは媒介体投与が標準です.
- DED試験におけるプラセボ/媒介効果の影響は十分に理解されていません.
研究 の 目的:
- DED媒介体またはプラセボ効果の存在と大きさを評価する.
- これらの効果に関連した要因を特定する.
- 将来のDED試験の設計を 伝えるために
主な方法:
- 媒介体またはプラセボ制御のDED試験の体系的レビューとメタ解析
- 試験の特徴と結果に関する抽出データ (シルマー試験,TBUT,染色,OSDI).
- ランダム効果モデルとメタ・リグレッションを使用して,プラセボ/ベヒクル効果と予測値を分析した.
主要な成果:
- OSDI (症状) とTBUT,角膜染色,結膜染色 (徴候) において有意なプラセボ/ベヒクル効果が観察されました.
- 女性参加者の割合が高く,OSDIのベースラインスコアが低いと,OSDIに対するプラセボ/媒介体の反応がより高いことが予測された.
- DEDの兆候に対するプラセボ/ベヒクル効果の予測要因は特定されていません.
結論:
- DED試験におけるプラセボ/媒介体効果は重要であり,試験設計において考慮しなければならない.
- DEDの症状に対するプラセボ効果はより大きい.
- DED試験におけるプラセボ効果のメカニズムと緩和戦略を理解するためにさらなる研究が必要です.
さらに関連する動画
08:04A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies
Published on: January 24, 2020
12.5K
04:06Author Spotlight: Challenges in Developing Dry Eye Animal Models and Future Research Directions
Published on: February 9, 2024
2.2K
関連する概念動画
Blind Procedures
12.1K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.1K
The Placebo Effect
6.3K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.3K
Blinding
2.6K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.6K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
869
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
869
Open Angle Glaucoma: Treatment
557
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
557
